Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Give genotype-guided dual antiplatelet therapy a second CHANCE.

European heart journal - 7 Mar 2022

Liuzzo Giovanna, Patrono Carlo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clopidogrel
Share to Genotype
Share to Platelet Aggregation Inhibitors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35075484
DOI: 10.1093/eurheartj/ehac024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Give genotype-guided dual antiplatelet therapy a second CHANCE.PMID 35075484Read ↗

Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk - Never Judge a Book by Its Cover.Semantic proximity Read ↗

Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.Semantic proximity Read ↗

Genotype- and phenotype-directed antiplatelet therapy selection in patients with acute coronary syndromes.Semantic proximity Read ↗

Genotype-guided antiplatelet treatment versus conventional therapy: A systematic review and meta-analysis.Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week.Semantic proximity Read ↗

Clopidogrel and Genotyping.Semantic proximity Read ↗

Point-Counterpoint: Genotype-Guided Warfarin Therapy.Semantic proximity Read ↗

Personalized medicine in cardiology: the time for genotype-guided therapy is now.Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?Semantic proximity Read ↗

Efficacy and safety of genotype-guided antiplatelet therapy versus standard treatment in 4,604 patients with CAD after PCI: a meta-analysis of randomized controlled trials.Semantic proximity Read ↗

Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.